| AR & VR in Healthcare Market by Key Types, Detail Analysis and Forecasts To 2030 |
|
| Market OverviewAR & VR in Healthcare Market is expected to grow at a CAGR of 27.30% during the forecast period. Virtual reality technology benefits both doctors and patients since it allows patients to virtually visit doctors, which is very conve |
| read more |
|
|
| Clinical Decision Support Systems Market Forecasts by Global Industry Till 2030 |
|
| Market Overview:With a 12 percent CAGR, the Clinical Decision Support Systems (CDSS) market is estimated to reach USD 1.76 billion by 2030. Clinical decision support systems (CDSS) are an essential component of the healthcare IT spectrum. Breakthroug |
| read more |
|
|
| Microfluidics Device Market by Key Types, Detail Analysis and Forecasts To 2030 |
|
| Microfluidics Device Market – Competitive AnalysisHighly competitive, the microfluidics market appears to be fragmented owing to the presence of several large and small-scale players. These players invest substantially in R&D to develop advance |
| read more |
|
|
| Vitamin D Testing Market 2022 Industry Overview, Analysis and Forecast by 2030 |
|
| Market HighlightsAccording to MRFR analysis, the global vitamin D testing market is expected to register a CAGR of ~6.1% during the forecast period of 2021 to 2027 and is expected to reach USD ~963.6million by 2027.Vitamin D, also referred to as calc |
| read more |
|
|
| Microcatheters Market Key Developments Trends, Analysis and Forecasts to 2030 |
|
| Market HighlightsAccording to MRFR analysis, the global microcatheters market is expected to register a CAGR of~4.1% from 2022 to 2030 and hold a value of ~USD 2,412.0 million in 2030.The global microcatheters market is driven by several factors, suc |
| read more |
|
|
| Antibiotics Market by Key Types, Detail Analysis and Forecasts To 2030 |
|
| Market ScopeMarket Research Future (MRFR) studied the global antibiotics market 2021 for the review period till 2030. As per MRFR analysis, the market of antibiotics is likely to register 4.8% CAGR over the analysis period. By 2030, the antibiot |
| read more |
|
|
